A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumors

被引：0
|
作者：
Laura Q. M. Chow
S. Gail Eckhardt
Cindy L. O’Bryant
Mary Kay Schultz
Mark Morrow
Stacy Grolnic
Michele Basche
Lia Gore
机构：
[1] University of Colorado Cancer Center,
[2] The Children’s Hospital,undefined
[3] University of Colorado Health Sciences Center at Fitzsimons,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 62卷
关键词：
Lonafarnib; SCH66336; Cisplatin; Gemcitabine; Farnesyltransferase; Phase I; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：631 / 646
页数：15
相关论文
共 50 条
  • [1] A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumors
    Chow, Laura Q. M.
    Eckhardt, S. Gail
    O'Bryant, Cindy L.
    Schultz, Mary Kay
    Morrow, Mark
    Grolnic, Stacy
    Basche, Michele
    Gore, Lia
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (04) : 631 - 646
  • [2] A phase I safety, pharmacological and biological study of the farnesyl protein transferase inhibitor, tipifarnib and capecitabine in advanced solid tumors
    Gore, L.
    Holden, S. N.
    Cohen, R. B.
    Morrow, M.
    Pierson, A. S.
    O'Bryant, C. L.
    Persky, M.
    Gustafson, D.
    Mikule, C.
    Zhang, S.
    Palmer, P. A.
    Eckhardt, S. G.
    ANNALS OF ONCOLOGY, 2006, 17 (11) : 1709 - 1717
  • [3] A phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer
    Adjei, AA
    Croghan, GA
    Erlichman, C
    Marks, RS
    Reid, JM
    Sloan, JA
    Pilot, HC
    Alberts, SR
    Goldberg, RM
    Hanson, LJ
    Bruzek, LM
    Atherton, P
    Thibault, A
    Palmer, PA
    Kaufmann, SH
    CLINICAL CANCER RESEARCH, 2003, 9 (07) : 2520 - 2526
  • [4] A phase I pharmacokinetic and pharmacodynamic study of the farnesyl transferase inhibitor BMS-214662 in combination with cisplatin in patients with advanced solid tumors
    Mackay, HJ
    Hoekstra, R
    Eskens, FALM
    Loos, WJ
    Crawford, D
    Voi, M
    Van Vreckem, A
    Evans, TRJ
    Verweij, J
    CLINICAL CANCER RESEARCH, 2004, 10 (08) : 2636 - 2644
  • [5] Phase I and pharmacokinetic study of the oral farnesyl transferase inhibitor SCH 66336 given twice daily to patients with advanced solid tumors
    Eskens, FALM
    Awada, A
    Cutler, DL
    de Jonge, MJA
    Luyten, GPM
    Faber, MN
    Statkevich, P
    Sparreboom, A
    Verweij, J
    Hanauske, AR
    Piccart, M
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) : 1167 - 1175
  • [6] A Phase I and pharmacokinetic study of the farnesyl transferase inhibitor, CP-609,754 in patients with advanced solid tumors
    Lush, R
    Mahany, J
    Langevin, M
    Bartkowski, M
    Noe, D
    Ferrante, K
    Sullivan, D
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S56 - S56
  • [7] A phase I and pharmacological study of the farnesyl protein transferase inhibitor L-778,123 in patients with solid malignancies
    Britten, CD
    Rowinsky, EK
    Soignet, S
    Patnaik, A
    Yao, SL
    Deutsch, P
    Lee, Y
    Lobell, RB
    Mazina, KE
    McCreery, H
    Pezzuli, S
    Spriggs, D
    CLINICAL CANCER RESEARCH, 2001, 7 (12) : 3894 - 3903
  • [8] A phase I, pharmacological and biological study of the farnesyl transferase inhibitor (FTI) R115977 and capecitabine in patients (pts) with advanced solid malignancies.
    Holden, SN
    Cohen, R
    Fisher, S
    Persky, M
    Mikule, C
    Morrow, M
    Richards, H
    Rodriguez, S
    Eckhardt, SG
    CLINICAL CANCER RESEARCH, 2000, 6 : 4573S - 4573S
  • [9] A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    Plummer, Ruth
    Madi, Ayman
    Jeffels, Melinda
    Richly, Heike
    Nokay, Bahar
    Rubin, Stephen
    Ball, Howard A.
    Weller, Steve
    Botbyl, Jeffrey
    Gibson, Diana M.
    Scheulen, Max E.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) : 93 - 101
  • [10] A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    Ruth Plummer
    Ayman Madi
    Melinda Jeffels
    Heike Richly
    Bahar Nokay
    Stephen Rubin
    Howard A. Ball
    Steve Weller
    Jeffrey Botbyl
    Diana M. Gibson
    Max E. Scheulen
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 93 - 101
12345